• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Godavari Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4985.0
  • ISIN : INE362C01012
119.70 1 (0.50%)
  • As on 06 Nov 2026 (EOD)

  • Today’s Low

    117.90

  • Today’s High

    120.00

  • Open

    118.30

  • Perv Close

    119.10

  • 52W Low

    69.70

  • 52W High

    144.35

Key Indicators

  • P/E(TTM)

    33.62

  • Mar.Cap (₹Cr.)

    130.64

  • Div & Yield %

    0.00

  • Book Value(₹)

    71.05

  • Debt-Equity Ratio

    0.50

  • AGM Date

    06-Nov-2026

  • EPS

    3.56

  • P/E Ratio

    33.62

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    130.64

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.91

  • BV (₹)

    71.10

  • Sales( ₹ in Cr.)

    105.81

  • NP (in Cr.)

    3.66

  • NP Var(%)

    -16.0

  • Div%

    0.0

  • CPS (₹)

    5.60

  • EPS (₹)

    3.40

  • Traded Value (₹ in Lakhs)

    129.99

  • 52 Week High

    144.35

  • 52 Week Low

    69.70

  • Price BSE

    119.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    129.99

  • P/C Ratio

    21.30

  • P/E Ratio

    35.50

  • Price Vs.BV

    3.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 105.81 113.35 156.71 159.62 161.11 122.67
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 105.81 113.35 156.71 159.62 161.11 122.67
Other Income 1.16 0.98 0.62 0.88 0.28 0.41
Stock Adjustments 11.39 3.58 1.14 9.76 -2.48 -2.44
Total Income 118.36 117.91 158.47 170.26 158.91 120.64
EXPENDITURE :            
Raw Materials 88.89 85.24 121.95 137.82 127.97 94.15
Power and Fuel Cost 5.09 6.92 8.51 6.66 5.46 4.76
Employee Cost 5.70 5.03 5.13 4.84 4.96 3.94
Other Manufacturing Expenses 2.39 3.19 3.07 3.27 4.14 3.15
Selling and Administration Expenses 1.78 1.46 1.50 1.27 1.38 1.24
Miscellaneous Expenses 3.05 3.27 4.47 5.60 3.42 3.16
Employee Benefit Expenses 5.70 5.03 5.13 4.84 4.96 3.94
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 106.89 105.10 144.64 159.47 147.33 110.39
Operating Profit 11.48 12.80 13.84 10.81 11.57 10.25
Interest 3.98 4.73 4.92 3.93 2.85 3.32
Gross Profit 7.50 8.07 8.92 6.88 8.72 6.93
Depreciation 2.43 2.45 1.99 1.94 1.70 1.22
Profit Before Tax 5.07 5.62 6.93 4.94 7.02 5.71
Current Tax 1.09 1.19 1.16 1.02 1.23 1.19
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.12 0.06 0.22 0.13 0.55 0.39
Reported Net Profit 4.09 4.38 5.55 3.79 5.25 4.13
Extraordinary Items 0.43 0.04 -0.07 0.18 0.00 0.00
Adjusted Net Profit 3.66 4.34 5.62 3.61 5.25 4.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 24.47 20.09 14.54 10.75 5.51 1.38
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 28.56 24.47 20.09 14.54 10.75 5.51
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.04 5.82 7.37 5.03 6.97 5.48
Earnings Per Share(Adj)-Unit Curr 4.04 5.82 7.37 5.03 6.97 5.48
Book Value 69.66 57.56 51.74 44.38 39.35 32.38
Book Value(Adj)-Unit Curr 69.66 57.56 51.74 44.38 39.35 32.38

Shareholding Pattern

  • Promoter Group

    44.54%

  • Public Share Holding

    55.46%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,860,781 44.54 4,860,781 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,860,781 44.54 4,860,781 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 37,500 0.34 0 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 132,555 1.21 132,555 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 112,360 1.03 112,360 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 282,415 2.59 244,915 6
2] Non Institution
Bodies Corporate 804,846 7.37 759,846 52
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 358,749 3.29 143,849 136
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 256,608 2.35 256,608 111
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,480,781 22.73 2,478,681 38
Individuals holding nominal share capital up to Rs. 1 lakh 1,869,945 17.13 1,679,292 6,395
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,770,929 52.88 5,318,276 6,732
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,914,125 100.00 10,423,972 6,750

Company Background

Godavari Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Godavari Drugs Ltd
  • BSE Code : 4985.0
  • ISIN : INE362C01012

  • Incorporation Year

    1987

  • Registered Office

    Mayfair 1-8-303-34
    Sardar Patel Road, Secunderabad,
    Andhra Pradesh-500003

  • Telephone

    91-40-27849700/27844557

  • FAX

    91-40-27849859

  • Chairman

    Ghanshyam Jaju

  • Managing Director

    Mukund Kakani

  • Company Secretary

    Venkatesh Achanta

  • Auditor

    Ayyadevara & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Godavari Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Godavari Drugs 119.70 106.61 105.81 31.42 6.77
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77